The novel treatment of the medication represents a major development in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets multiple pathways – the GLP-1 hormone and glucose-dependent https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment